- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors ; day:30 ; month:03 ; year:2021 ; extent:3
EMBO molecular medicine / European Molecular Biology Organization ; (30.03.2021) (gesamt 3)
- Creator
-
Angers, Stephane
- DOI
-
10.15252/emmm.202114002
- URN
-
urn:nbn:de:101:1-2021033115144148480695
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Angers, Stephane
Other Objects (12)
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Modeling synthetic lethality
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Modeling synthetic lethality
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Modeling synthetic lethality
Synthetic lethality of PARP and NAMPT inhibition in triple‐negative breast cancer cells
Synthetic lethality by PARP inhibitors: new mechanism uncovered based on unresolved transcription-replication conflicts
Exploiting Synthetic lethality between Germline BRCA1 haploinsufficiency and PARP inhibition in JAK2V617F-positive myeloproliferative neoplasms
ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
ATM-depletion in breast cancer cells confers sensitivity to PARP inhibition
PINX1 loss confers susceptibility to PARP inhibition in pan-cancer cells